Evidence map›Paper›PMID 39722715›Full record

Observational studyFrontiers in public health2024

A cost-reducing reimbursement programme? Effects of value-based reimbursement on healthcare costs.

Thérèse Eriksson, Hans Tropp, Ann-Britt Wiréhn, Lars-Åke Levin

Abstract readObservational Study
In one paragraph

Observational study in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thérèse ErikssonDepartment of Health, Medicine and Caring Sciences (HMV), Linköping University, Linköping, Sweden.
Hans TroppDepartment of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Ann-Britt WiréhnUnit for strategic healthcare in Region Östergötland, Linköping, Sweden.
Lars-Åke LevinDepartment of Health, Medicine and Caring Sciences (HMV), Linköping University, Linköping, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Value-based reimbursement programmes have become increasingly common in attempts to bend the cost curve of healthcare without negative effects on quality. The aim of this study was to analyse the effect of introducing a value-based reimbursement programme on the cost to third-party payer. We performed a retrospective observational study with a before and after design based on the introduction of a value-based reimbursement programme in Sweden. We analysed patient level cost data from inpatient and outpatient care of patients undergoing lumbar spine surgery, 2006-2015. The average 1-year episode cost decreased 11 percent during the first 2 years with the value-based reimbursement. The number of patients increased 22 percent during the same period, causing the total cost to increase by 8 percent. The value to third-party payer increased after the introduction of the value-based reimbursement since more patients were treated and attained a positive outcome. The decreased episode cost may be a result of better coordinated post-discharge care. Another explanation could be that costs previously borne by the third-party payer are shifted onto the healthcare providers. Thus, it is crucial that providers find a sustainable way of delivering care in the long term to retain value. Interlinking patient records facilitates a holistic perspective among healthcare providers raising awareness of health care utilization through the whole care chain.

Indexed as

Health Care CostsAdultAgedCost ControlFemaleHumansInsurance, Health, ReimbursementMaleMiddle AgedReimbursement MechanismsRetrospective StudiesSwedenbundled paymentcostEQ-5Dhealthcare cost and resource utilizationpay-for-performancePROM (patient reported outcome measures)reimbursementvalue-based

Identifiers

PMID39722715
PMCPMC11668751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.